Table 1.
KEGG enrichments of target mRNAs in miRNA-mRNA networks of obesity in VAT and SAT.
| ID | Description | GeneRatio | P-value | geneID | Count |
|---|---|---|---|---|---|
| VAT | |||||
| hsa05033 | Nicotine addiction | 2/37 | 0.014244 | CHRNA7/GABRA6 | 2 |
| hsa04725 | Cholinergic synapse | 3/37 | 0.014618 | CACNA1F/CHRNA7/SLC5A7 | 3 |
| hsa04270 | Vascular smooth muscle contraction | 3/37 | 0.022488 | ARAF/CACNA1F/CALCRL | 3 |
| hsa04978 | Mineral absorption | 2/37 | 0.029596 | ATP2B2/MT1A | 2 |
| hsa05223 | Non-small cell lung cancer | 2/37 | 0.042611 | ALK/ARAF | 2 |
| hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 2/37 | 0.048094 | CACNA1F/CDH2 | 2 |
| SAT | |||||
| hsa04972 | Pancreatic secretion | 3/36 | 0.010288 | ATP1A2/PLA2G1B/RAP1A | 3 |
| hsa00072 | Synthesis and degradation of ketone bodies | 1/36 | 0.043658 | HMGCS2 | 1 |
| hsa03320 | PPAR signaling pathway | 2/36 | 0.044704 | ACSL4/HMGCS2 | 2 |
| hsa03018 | RNA degradation | 2/36 | 0.04793 | ENO2/WDR61 | 2 |
KEGG, Kyoto Encyclopedia of Genes and Genomes; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue.